{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:52Z","timestamp":1786119292162,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/mph.0b013e318196a2a6","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:34:35Z","timestamp":1242898475000},"page":"224-225","source":"Crossref","is-referenced-by-count":2,"title":["High-dose Methotrexate: The Rationale\u2026"],"prefix":"10.1097","volume":"31","author":[{"given":"Meyling H.","family":"Cheok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Kager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210227","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPH.0b013e318185f4ee","article-title":"High-dose methotrexate: insecure rationale: take 2","volume":"30","author":"Kamen","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-19-20210227","first-page":"226","article-title":"Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle","volume":"30","author":"Blay","year":"2007","journal-title":"Onkologie"},{"key":"R3-19-20210227","first-page":"228","article-title":"Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients","volume":"30","author":"Tunn","year":"2007","journal-title":"Onkologie"},{"key":"R4-19-20210227","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2007.14.7793","article-title":"High-dose methotrexate in osteosarcoma: let the questions surcease\u2014time for final acceptance","volume":"26","author":"Jaffe","year":"2008","journal-title":"J Clin Oncol"},{"key":"R5-19-20210227","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1371\/journal.pmed.0050083","article-title":"In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile","volume":"5","author":"Sorich","year":"2008","journal-title":"PLoS Med"},{"key":"R6-19-20210227","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI118409","article-title":"Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate","volume":"97","author":"Masson","year":"1996","journal-title":"J Clin Invest"},{"key":"R7-19-20210227","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1172\/JCI117552","article-title":"Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia","volume":"94","author":"Synold","year":"1994","journal-title":"J Clin Invest"},{"key":"R8-19-20210227","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJM198602203140803","article-title":"Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect","volume":"314","author":"Evans","year":"1986","journal-title":"N Engl J Med"},{"key":"R9-19-20210227","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"N Engl J Med"},{"key":"R10-19-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00043426-200403000-00004","article-title":"Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system","volume":"26","author":"Cohen","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R11-19-20210227","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI22477","article-title":"Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics","volume":"115","author":"Kager","year":"2005","journal-title":"J Clin Invest"},{"key":"R12-19-20210227","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.leu.2403703","article-title":"Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"19","author":"Whitehead","year":"2005","journal-title":"Leukemia"},{"key":"R13-19-20210227","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1200\/JCO.2003.08.047","article-title":"CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials","volume":"21","author":"Clarke","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e318196a2a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:57Z","timestamp":1786038897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200903000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318196a2a6","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}